Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie, Xiong"'
Autor:
Aoi Ogawa, Christophe Golé, Maria Bermudez, Odrine Habarugira, Gabrielle Joslin, Taylor McCain, Autumn Mineo, Jennifer Wise, Julie Xiong, Katherine Yan, Jan A. C. Vriezen
Publikováno v:
Applied and environmental microbiology. 88(23)
Over the last 4 decades, the rate of discovery of novel antibiotics has decreased drastically, ending the era of fortuitous antibiotic discovery. A better understanding of the biology of bacteriogenic toxins potentially helps to prospect for new anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e75e57c00a0358d80be787b1c870ac15
https://pubmed.ncbi.nlm.nih.gov/36374088
https://pubmed.ncbi.nlm.nih.gov/36374088
Autor:
Alison K. Bauer, Rana Brooks, Ka-Na Xiong, Carla-Maria Alexander, Kalpana Velmurugan, Julie Xiong
Publikováno v:
Molecular Carcinogenesis. 56:94-105
Adenocarcinoma accounts for ∼40% of lung cancer, equating to ∼88 500 new patients in 2015, most of who will succumb to this disease, thus, the public health burden is evident. Unfortunately, few early biomarkers as well as effective therapies exi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbf0033dd8afcae9762519bab58e9db8
https://doi.org/10.1002/mc.22475
https://doi.org/10.1002/mc.22475
Autor:
Ka-Na Xiong, Kalpana Velmurugan, Ross S. Osgood, Carla-Maria Alexander, Alison K. Bauer, Julie Xiong
Publikováno v:
Experimental lung research. 42(3)
Tumor promotion is an early and critical stage during lung adenocarcinoma (ADC). We previously demonstrated that Tlr4 mutant mice were more susceptible to butylated hydroxytoluene (BHT)-induced pulmonary inflammation and tumor promotion in comparison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f26caca30c828c65cd3289dcee88bb2f
https://pubmed.ncbi.nlm.nih.gov/27093379
https://pubmed.ncbi.nlm.nih.gov/27093379
Autor:
Alison K, Bauer, Kalpana, Velmurugan, Ka-Na, Xiong, Carla-Maria, Alexander, Julie, Xiong, Rana, Brooks
Publikováno v:
Molecular carcinogenesis. 56(1)
Adenocarcinoma accounts for ~40% of lung cancer, equating to ~88,500 new patients in 2015, most of who will succumb to this disease, thus, the public health burden is evident. Unfortunately, few early biomarkers as well as effective therapies exist,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00718a6faa2cdf34f5000e83cb837def
https://pubmed.ncbi.nlm.nih.gov/26894620
https://pubmed.ncbi.nlm.nih.gov/26894620